XML 93 R73.htm IDEA: XBRL DOCUMENT
v3.25.2

Net Loss Per Share Attributable to Common Shareholders - Additional Information (Details) - shares | 12 Months Ended
--- | ---
Apr. 30, 2025 | Apr. 30, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Dilutive shares | 0 | 0
Parent contribution of common stock | 105,808 |
Kestra Medical Technologies, Ltd |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Parent contribution of common stock | 19,885,382 |
Warrants |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Potentially anti-dilutive shares excluded from the calculation of diluted net loss per share | 434,916 |
Restricted Stock |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Potentially anti-dilutive shares excluded from the calculation of diluted net loss per share | 32,485 | 23,899
Stock Options |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |
Potentially anti-dilutive shares excluded from the calculation of diluted net loss per share | 4,649,100 |

X
- Definition Parent contribution of common stock. + References No definition available. + Details
Name: | ck0001877184_ParentContributionOfCommonStock
Namespace Prefix: | ck0001877184_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_EntityListingsExchangeAxis=ck0001877184_KestraMedicalTechnologiesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |